|
HNRPDL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.121800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.891600E-01 |
| Normal-vs-Stage2 |
2.256400E-01 |
| Normal-vs-Stage3 |
4.793100E-04 |
| Normal-vs-Stage4 |
2.765100E-04 |
| Stage1-vs-Stage2 |
1.285980E-01 |
| Stage1-vs-Stage3 |
1.75845000000008E-05 |
| Stage1-vs-Stage4 |
2.53139999994989E-06 |
| Stage2-vs-Stage3 |
1.962030E-01 |
| Stage2-vs-Stage4 |
1.414750E-01 |
| Stage3-vs-Stage4 |
7.527600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.892100E-02 |
| Normal-vs-AfricanAmerican |
5.144200E-01 |
| Normal-vs-Asian |
5.413200E-01 |
| Caucasian-vs-AfricanAmerican |
2.638400E-02 |
| Caucasian-vs-Asian |
8.830800E-01 |
| AfricanAmerican-vs-Asian |
4.621800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.903400E-03 |
| Normal-vs-Female |
9.881800E-01 |
| Male-vs-Female |
2.627500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.042400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.838400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.867700E-02 |
| Normal-vs-Age(81-100Yrs) |
5.709800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.735800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.868200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.143600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.911000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.368200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.831800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.661400E-03 |
| Normal-vs-Grade 2 |
4.139000E-01 |
| Normal-vs-Grade 3 |
6.033500E-04 |
| Normal-vs-Grade 4 |
2.36889999949419E-07 |
| Grade 1-vs-Grade 2 |
2.147700E-02 |
| Grade 1-vs-Grade 3 |
1.67470000000947E-06 |
| Grade 1-vs-Grade 4 |
4.34769997781359E-09 |
| Grade 2-vs-Grade 3 |
5.74740000036655E-09 |
| Grade 2-vs-Grade 4 |
2.65898414397725E-12 |
| Grade 3-vs-Grade 4 |
9.517100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.291200E-01 |
| Normal-vs-ccB subtype |
5.43670000019425E-07 |
| ccA subtype-vs-ccB subtype |
3.33066907387547E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.009900E-02 |
| Normal-vs-N1 |
3.499100E-03 |
| N0-vs-N1 |
6.418000E-02 |
|
|
